Editorial
doi: 10.1001/jama.2011.1866.
Epub 2011 Dec 12.
ADHD medications and cardiovascular risk: some heartening news
- PMID: 22161945
- DOI: 10.1001/jama.2011.1866
Item in Clipboard
Editorial
ADHD medications and cardiovascular risk: some heartening news
JAMA.
.
No abstract available
Comment on
-
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.JAMA. 2011 Dec 28;306(24):2673-83. doi: 10.1001/jama.2011.1830. Epub 2011 Dec 12. JAMA. 2011. PMID: 22161946 Free PMC article.
Similar articles
-
Cardiovascular events in adults taking medications for ADHD.JAMA. 2012 Apr 11;307(14):1485-6; author reply 1486. doi: 10.1001/jama.2012.448. JAMA. 2012. PMID: 22496258 No abstract available.
-
Stimulant medications and attention deficit-hyperactivity disorder.N Engl J Med. 2006 May 25;354(21):2294-5. doi: 10.1056/NEJMc060860. N Engl J Med. 2006. PMID: 16723627 No abstract available.
-
Encouraging news about ADHD drugs and heart risk in adults.Harv Ment Health Lett. 2012 Mar;28(9):7. Harv Ment Health Lett. 2012. PMID: 22474711 No abstract available.
-
Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.Expert Opin Drug Saf. 2010 Nov;9(6):917-35. doi: 10.1517/14740338.2010.503238. Expert Opin Drug Saf. 2010. PMID: 20615078 Review.
-
Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Expert Opin Drug Saf. 2015 Apr;14(4):543-51. doi: 10.1517/14740338.2015.1011620. Epub 2015 Feb 3. Expert Opin Drug Saf. 2015. PMID: 25648243 Review.
Cited by
-
How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD.ISRN Pharmacol. 2012;2012:170935. doi: 10.5402/2012/170935. Epub 2012 Mar 5. ISRN Pharmacol. 2012. PMID: 22530135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
